Ivan Rodriguez Rosello posted this:
Licensing Manager at Universidad de Alicante
Technology Transfer OfficeView Profile
Yissum - Research Development Company of the Hebrew University posted this:Novel Naturally Occurring Compounds for Treating Cystic FibrosisCannabis project Derivatives of cannabinoids have an antimicrobial and anti biofilm effect on pseudomonas and candida which are major ethological pathogenic factors in CF Project ID : 6-2019-6720
Consejo Superior de Investigaciones Científicas posted this:Molecular Method that radically improves the diagnosis of Hereditary hemorrhagic telangiectasia (HHT)Molecular Method that radically improves the diagnosis of Hereditary hemorrhagic telangiectasia (HHT). The Granada University, Health and Progress Foundation, and the CSIC have developed a diagnostic molecular system for the HHT by getting a simple liquid biopsy from the patient. Industrial partners are being sought to collaborate through a patent license agreement to use this molecular diagnostic system with the possibility of informatics support.
Radoslaw Rudz posted this:
Licensing Manager at Centre Technology Transfer CITTRU
Avazyme posted this:Food safety, quality, authenticity and consulting servicesAvazyme offers agile and custom problem solving services to the food industry through the application of biological and chemical analytics. Differentiated from larger CROs that offer a rigid standardized menu of services, Avazyme is focused first on agile problem solving. Avazyme has state-of-the-art instrumentation and methodologies. Problem solving is applied to food safety, quality, authenticity and GMO testing. Avazyme also offers consulting in food regulatory science, Maximum Residue Levels (MRLs), import tolerances and food safety, quality and secondary standards, nutritional labeling, authenticity and GMO analysis. Consulting in new assay development, validation and certificate of analysis is also offered. Differentiated from larger CROs, Avazyme offers nimble, rapid and custom analytical method development and validation. Offers include development of laboratory and point of use assays. Avazyme offers organizations Independent Lab Validation (ILV). Avazyme is BSL2, EPA GLP, FDA GLP compliant and will work with companies requiring GMP and ISO17025 standards.
UACOOPERA University of Aveiro posted this:
Technology Transfer Office at uacoopera
Lidia Aguilera posted this:
Technology Transfer Officer at University of Luxembourg
CD Genomics posted this:DNA & Genomics Sequencing ServiceCD Genomics proprietary GenSeqTM Technology provides advanced multi-omics and bioinformatics service solutions for its global The Specialties of GenSeqTM customers who do research in laboratory. Equipped with the broadest industrial array of cutting-edge technologies and coupled with a group of experienced scientists and bioinformaticians, CD Genomics possesses significant contributions to genetic research.
Universidad de Alcalá-OTRI posted this:Synthesis of dendritic systems of nanoscopic size for applications in biomedicineRegarding the cationic systems developed, the principal innovative aspects are the following: - They are non viral nanoscopic synthetic molecules able to internalise nuclear material inside different cellular lines. This turns them into good candidates to be considered as non viral vectors in gene therapy processes. - They are non toxic in a concentration range adapted for the accomplishment of different biomedical studies. - They present antibacterial properties against gram + and gram- bacteria - They are able of interacting, in a electrostatic way, with anionic drugs which turns them into drug delivery systems. - They present a hydrophobic carbosilane skeleton that allows the molecules to cross the cellular membranes with major facility. - They are soluble in water. Regarding the anionic systems developed, the principal innovative aspects are the following: - They have an important antiviral capacity - They are able to inhibit the infection for HIV - They have antiinflammatory capacity - They are good candidates for the production of a microbicide gel of topic use that prevents the infection of the virus across sexual transmission.
uacoopera posted this:DNA Barcodes – DNA authentication mark (traceability and identification of food products)The present invention consists on the development and application of "molecular tags" or “molecular barcoded labels”, of easy synthesis and production in large quantities. These labels are of simple application, invisible to the naked eye and of rapid detection using low cost equipments and reagents typically used for molecular biology. Basically, the labels consist of chimerical molecules of deoxyribonucleic acid (DNA) and the detection and read of these molecules do not depend on sequencing approaches. The information in these labels can be accessed in a similar way as it is done for most common barcoded systems.
Centre Technology Transfer CITTRU posted this:New method for efficient isolation of microbial DNA from bloodThe method of the invention is a solution that allows the simultaneous isolation of microbial DNA from the blood. In this method the isolation is carried out by compilation of enzymatic, mechanical and thermal lysis. This approach enables to obtain DNA from all types of organisms, irrespective of the structure of the cells.The obtained precipitate is subjected to further preparations, using a commercial DNA isolation kit according to the protocol provided by the manufacturer's procedure. The procedure results in obtaining the DNA ready for further stages of the analysis, e.g. performing a PCR reaction to detect fungi. The most important and most difficult problem in the treatment of bloodstream infections, determining the effectiveness of therapy and, consequently, the cost and time of hospitalization, is the effective diagnosis of factors responsible for the systemic inflammatory response in the course of sepsis. Determination of etiologic factors allows for selection of appropriate antibiotic therapy. The material subjected to diagnostic testing is blood taken from the patient showing clinical signs of sepsis. Currently, the "gold standard" diagnostic method is testing for microbial growth after inoculation in culture media specific to selected pathogen groups. This method is relatively simple and inexpensive, but also time-consuming – results can be available as late as in 5 days. Moreover, identification of pathogens with this method often fails due to low sensitivity; microbial growth can be detected in only about 15-20% of the cultures.
CD Genomics posted this:Whole Genome SNP Genotyping ServiceCD Genomics provides whole-genome SNP genotyping for the overview of the entire genome by using both microarray technologies and high-throughput next-generation sequencing (NGS), enabling genome-wide discoveries and screening of the SNP loci.
CD Genomics posted this:Whole Genome SNP Genotyping / SNP MicroarrayCD Genomics offers SNP Microarray service to interrogate up to five million SNPs in a single assay, allowing genome-wide SNP genotyping needs, and providing you with the reliable, high quality data you need to study genetic variations that contribute to disease, drug and vaccine response, environmental factor response, and other phenotypic characteristics.
Small and Medium Enterprise
Creative Proteomics posted this:2,2,4,4,6-PENTABDE (BDE-100) 50 UG/ML IN NONANE UNLABELED CERTIFIED STANDARDCreative Proteomics provides a full range of drug development services, including Molecular Biology, Biochemistry, Systems Biology, Organic Chemistry, Genomics, Bioinformatics, Structural Biology, Preclinical and Clinical studies. Please contact us to know more about 2,2,4,4,6-PENTABDE (BDE-100) 50 UG/ML IN NONANE UNLABELED CERTIFIED STANDARD!
jaume mir posted this:
CEO at Biochemize SL